Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
株式のランク #39280
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
株価
$2.06
最終同期: 2026-08-11
時価総額
$572.30K
変化(1日)
0.00%
変化(1年)
-90.38%
CA
取引 XORTX Therapeutics Inc. (XRTX)

カテゴリー

XORTX Therapeutics Inc.(XRTX)の株価履歴
終値の最高値: $2.06 (2026-08-01)

終値の最安値: $173.60 (2015-10-01)
XORTX Therapeutics Inc. の株価履歴(2015 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -27.44%
2025 -48.32%
2024 -50.05%
2023 -69.00%
2022 -58.91%
2021 105.10%
2020 -34.17%
2019 8.63%
2018 152.77%
2017 -20.67%
2016 22.14%
2015 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$517.18 32.51%
US
$857.76 31.47%
NL
$728.31 6.63%
CH
$1.07K -6.40%
KR
$254.43 12.40%
BE